| Dr Lorraine C Novich-welter, MD | |
|
267 N Spring Creek Pkwy, Providence, UT 84332-9775 | |
| (435) 792-9400 | |
| (435) 792-4800 |
| Full Name | Dr Lorraine C Novich-welter |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 25 Years |
| Location | 267 N Spring Creek Pkwy, Providence, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497741383 | NPI | - | NPPES |
| 11004941 | Other | ID | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 5924248-1205 (Utah) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | M-10473 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Utah Hospitals And Clinics | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Utah Adult Services | 0941525273 | 1435 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, today announced that they have entered into a licensing agreement granting exclusive rights to Norgine to develop, manufacture and commercialize prescription immediate-release ZEGERID® products incorporating the proton pump inhibitor omeprazole in combination with one or more buffering agents in specified markets in Western, Central and Eastern Europe.
U.S. Anesthesia Partners, the nation's largest anesthesia-focused, single-specialty physician services organization, and Pinnacle Anesthesia Consultants of Dallas, Texas today announced their partnership with Excel Anesthesia, P.A.
Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study led by UCL (University College London) researchers and funded by the British Heart Foundation and Barts Charity.
Kaiser Health News' Kate Steadman surveys the blogosphere to see how recent polls on health reform are playing. Her finding: "There's little consensus among bloggers about trends in public opinion toward the health care overhaul bills" (Steadman, 3/11).
Using low- rather than high-oxygen-concentration resuscitation gas for preterm infants cannot be recommended on the basis of available evidence, say researchers.
› Verified 8 days ago
| Entity Name | Lori C. Novich-welter, M.d., P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336412733 PECOS PAC ID: 7012178544 Enrollment ID: O20120410000696 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, today announced that they have entered into a licensing agreement granting exclusive rights to Norgine to develop, manufacture and commercialize prescription immediate-release ZEGERID® products incorporating the proton pump inhibitor omeprazole in combination with one or more buffering agents in specified markets in Western, Central and Eastern Europe.
U.S. Anesthesia Partners, the nation's largest anesthesia-focused, single-specialty physician services organization, and Pinnacle Anesthesia Consultants of Dallas, Texas today announced their partnership with Excel Anesthesia, P.A.
Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study led by UCL (University College London) researchers and funded by the British Heart Foundation and Barts Charity.
Kaiser Health News' Kate Steadman surveys the blogosphere to see how recent polls on health reform are playing. Her finding: "There's little consensus among bloggers about trends in public opinion toward the health care overhaul bills" (Steadman, 3/11).
Using low- rather than high-oxygen-concentration resuscitation gas for preterm infants cannot be recommended on the basis of available evidence, say researchers.
› Verified 8 days ago
| Entity Name | University Of Utah Adult Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, today announced that they have entered into a licensing agreement granting exclusive rights to Norgine to develop, manufacture and commercialize prescription immediate-release ZEGERID® products incorporating the proton pump inhibitor omeprazole in combination with one or more buffering agents in specified markets in Western, Central and Eastern Europe.
U.S. Anesthesia Partners, the nation's largest anesthesia-focused, single-specialty physician services organization, and Pinnacle Anesthesia Consultants of Dallas, Texas today announced their partnership with Excel Anesthesia, P.A.
Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study led by UCL (University College London) researchers and funded by the British Heart Foundation and Barts Charity.
Kaiser Health News' Kate Steadman surveys the blogosphere to see how recent polls on health reform are playing. Her finding: "There's little consensus among bloggers about trends in public opinion toward the health care overhaul bills" (Steadman, 3/11).
Using low- rather than high-oxygen-concentration resuscitation gas for preterm infants cannot be recommended on the basis of available evidence, say researchers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lorraine C Novich-welter, MD 267 N Spring Creek Pkwy, Providence, UT 84332-9775 Ph: (435) 792-9400 | Dr Lorraine C Novich-welter, MD 267 N Spring Creek Pkwy, Providence, UT 84332-9775 Ph: (435) 792-9400 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, today announced that they have entered into a licensing agreement granting exclusive rights to Norgine to develop, manufacture and commercialize prescription immediate-release ZEGERID® products incorporating the proton pump inhibitor omeprazole in combination with one or more buffering agents in specified markets in Western, Central and Eastern Europe.
U.S. Anesthesia Partners, the nation's largest anesthesia-focused, single-specialty physician services organization, and Pinnacle Anesthesia Consultants of Dallas, Texas today announced their partnership with Excel Anesthesia, P.A.
Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study led by UCL (University College London) researchers and funded by the British Heart Foundation and Barts Charity.
Kaiser Health News' Kate Steadman surveys the blogosphere to see how recent polls on health reform are playing. Her finding: "There's little consensus among bloggers about trends in public opinion toward the health care overhaul bills" (Steadman, 3/11).
Using low- rather than high-oxygen-concentration resuscitation gas for preterm infants cannot be recommended on the basis of available evidence, say researchers.
› Verified 8 days ago